SCHEMBL21539976

SCHEMBL21539976

CCN1C(=O)c2ccccc2C1(OCCCCO)c1ccc(Cl)cc1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 20/20 0.79
TP53 P04637 6/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4915376 0.88 MDM2 (1.00) MDM2TP53
SCHEMBL4915381 0.88 MDM2 (1.00) MDM2TP53
SCHEMBL1820890 0.86 MDM2 (0.84) MDM2TP53
SCHEMBL4907023 0.85 MDM2 (1.00) MDM2TP53
SCHEMBL18568901 0.85 MDM2 (1.00) MDM2TP53
SCHEMBL4907029 0.85 MDM2 (1.00) MDM2TP53
SCHEMBL12305342 0.84 MDM2 (1.00) MDM2TP53
SCHEMBL2458472 0.84 MDM2 (1.00) MDM2TP53
SCHEMBL1820888 0.82 MDM2 (1.00) MDM2TP53
SCHEMBL7987991 0.82 MDM2 (1.00) MDM2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2960233-B1 NEW THERAPEUTIC AGENTS CANCER RESEARCH TECH LTD (GB) 2019-10-30 EP disclosed